Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/109917
Title: Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas
Authors: Puget, Stephanie
Philippe, Cathy
Bax, Dorine A.
Job, Bastien
Varlet, Pascale
Junier, Marie-Pierre
Andreiuolo, Felipe
Carvalho, Dina 
Reis, Ricardo
Guerrini-Rousseau, Lea
Roujeau, Thomas
Dessen, Philippe
Richon, Catherine
Lazar, Vladimir
Le Teuff, Gwenael
Sainte-Rose, Christian
Geoerger, Birgit
Vassal, Gilles
Jones, Chris
Grill, Jacques
Issue Date: 2012
Publisher: Public Library of Science
Project: Canceropole Ile de France – Institut National de Cancer (INCa) 
LEM-Recherche (Les Entreprises du Médicament) 
association ‘‘L’Etoile de Martin 
Association pour la Recherche en Neurochirurgie Pe´diatrique (ARNP) 
metadata.degois.publication.title: PLoS ONE
metadata.degois.publication.volume: 7
metadata.degois.publication.issue: 2
Abstract: Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we have carried out integrated molecular profiling of a large series of samples obtained with stereotactic biopsy at diagnosis. While chromosomal imbalances did not distinguish DIPG and supratentorial tumors on CGHarrays, gene expression profiling revealed clear differences between them, with brainstem gliomas resembling midline/thalamic tumours, indicating a closely-related origin. Two distinct subgroups of DIPG were identified. The first subgroup displayed mesenchymal and pro-angiogenic characteristics, with stem cell markers enrichment consistent with the possibility to grow tumor stem cells from these biopsies. The other subgroup displayed oligodendroglial features, and appeared largely driven by PDGFRA, in particular through amplification and/or novel missense mutations in the extracellular domain. Patients in this later group had a significantly worse outcome with an hazard ratio for early deaths, ie before 10 months, 8 fold greater that the ones in the other subgroup (p = 0.041, Cox regression model). The worse outcome of patients with the oligodendroglial type of tumors was confirmed on a series of 55 paraffin-embedded biopsy samples at diagnosis (median OS of 7.73 versus 12.37 months, p = 0.045, log-rank test). Two distinct transcriptional subclasses of DIPG with specific genomic alterations can be defined at diagnosis by oligodendroglial differentiation or mesenchymal transition, respectively. Classifying these tumors by signal transduction pathway activation and by mutation in pathway member genes may be particularily valuable for the development of targeted therapies.
URI: http://hdl.handle.net/10316/109917
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0030313
Rights: openAccess
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais

Show full item record

Page view(s)

50
checked on Nov 5, 2024

Download(s)

37
checked on Nov 5, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons